Enzymotec Announces Changes To Its Board Of Directors

Published: Jan 02, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MIGDAL HA'EMEQ, Israel, Jan. 2, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-functional lipid ingredients, announced today that it has appointed Steve Dubin as Chairman of its board of directors, effective January 1, 2014.

Help employers find you! Check out all the jobs and post your resume.

Back to news